GlutaOne 1200 mg should be kept at a controlled temperature of 2 °C to 8 °C (36 °F to 46 °F), protected from excess humidity (35 %–65 % RH) and direct light, and stored in its original sealed packaging until use. These conditions preserve the product’s potency and ensure patient safety. Maintaining the integrity of glutathione formulations is particularly critical because this active ingredient is susceptible to oxidation, thermal degradation, and photolytic breakdown. Improper storage can compromise the molecular stability of the compound, potentially reducing its therapeutic efficacy and introducing safety concerns for patients receiving intravenous or intramuscular administration. The recommended storage parameters have been established through extensive stability studies conducted under various environmental conditions, and they represent the optimal range for preserving the pharmaceutical quality of the product throughout its shelf life. Facilities handling this medication should implement comprehensive storage protocols that address temperature monitoring, humidity control, light protection, and packaging integrity verification. These protocols should be documented in standard operating procedures (SOPs) and regularly audited to ensure compliance with both regulatory requirements and manufacturer specifications. For a quick reference and to order the product, see the official product page for glutaone 1200mg.
Storage Condition Overview
The following table provides a comprehensive summary of the critical storage parameters that must be maintained throughout the handling, transportation, and storage of GlutaOne 1200 mg. Each parameter has been evaluated based on stability data, regulatory guidelines, and practical considerations for healthcare settings. The recommended ranges represent the optimal conditions for maintaining product quality, while the critical limits define the boundaries beyond which product integrity may be compromised. Healthcare professionals should familiarize themselves with these parameters and ensure that all staff involved in product handling are adequately trained in storage requirements.
| Parameter | Recommended Range | Critical Limit | Notes |
|---|---|---|---|
| Temperature | 2 °C – 8 °C (36 °F – 46 °F) | ≤ 15 °C for up to 24 h (short‑term excursions allowed) | Use a calibrated pharmaceutical refrigerator; avoid freezing |
| Relative Humidity | 35 % – 65 % RH | ≤ 75 % RH (short‑term) | Include desiccant packs in high‑humidity environments |
| Light Exposure | Original amber vials, store in darkness | Avoid direct sunlight or UV light | Use opaque containers or shelving when possible |
| Packaging | Sealed glass vials, sealed pouches, nitrogen‑flushed | Inspect seal integrity before use | Do not use if seal is broken or compromised |
| Physical Handling | Minimize agitation; avoid mechanical shock | Avoid dropping or impact stress | Handle with care during transport and storage |
| Inventory Rotation | First‑in, first‑out (FIFO) principle | Do not use expired products | Maintain clear labeling of receipt dates |
Key Steps for Maintaining Proper Storage
The following detailed procedures should be implemented in any healthcare facility handling GlutaOne 1200 mg to ensure compliance with storage requirements and maintain product quality throughout the supply chain. Each step includes specific actions and verification criteria that personnel should follow consistently.
- Set up the storage unit
- Choose a dedicated pharmaceutical refrigerator with forced‑air circulation to ensure uniform temperature distribution throughout the interior compartment. The refrigerator should be sized appropriately for the volume of product being stored while maintaining adequate space for air circulation around all items.
- Install a continuous temperature‑monitoring system with an alarm set at ±2 °C from the target. The monitoring system should provide both visual and audible alerts when temperatures deviate from the acceptable range, and it should record temperature data continuously for documentation purposes.
- Place a backup data logger (e.g., USB‑type) that records temperature every 15 minutes. This redundant recording system provides insurance against primary system failure and creates an auditable record of storage conditions that can be reviewed during regulatory inspections or quality audits.
- Position the refrigerator away from direct sunlight, heating vents, or air conditioning outlets to minimize external temperature influences. Maintain a consistent ambient room temperature between 20 °C and 25 °C in the storage area.
- Calibrate temperature monitoring equipment at least annually or according to manufacturer recommendations, and document all calibration activities in the facility’s quality management system.
- Receive and inspect shipments
- Check temperature‑indicator labels on the box (e.g., TTI‑2, 3M Cold Chain) upon delivery. These time-temperature indicators provide visual confirmation that the product has not been exposed to temperature excursions during transit. Reject any shipment where indicators show exceeded limits.
- Verify that the packaging is intact and that the expiry date is at least 12 months away. Products with shorter remaining shelf life should be prioritized for use, and those approaching expiration should be quarantined and managed according to facility discard procedures.
- Record the lot number and storage start date in the pharmacy inventory system. This information enables efficient recall management, inventory tracking, and quality investigation if stability concerns arise with specific batches.
- Inspect vials for physical damage including cracks, chips, or deformation that could compromise seal integrity. Any damaged units should be immediately segregated and disposed of according to hazardous waste procedures.
- Document the condition of the shipment, including any observed deviations from expected storage conditions, and report findings to the quality assurance department and supplier as appropriate.
- Daily checks
- Log refrigerator temperature twice daily (morning and evening) using calibrated thermometers or the continuous monitoring system. Record both the actual temperature reading and the time of observation in the designated logbook or electronic system.
- Inspect vial seals for cracks or discoloration. Any signs of seal compromise should trigger immediate removal of the affected unit from inventory and notification of the pharmacy supervisor for quality assessment.
- Ensure the desiccant packet (if present) is not saturated. Saturated desiccants should be replaced, and the product should be evaluated for potential moisture exposure before being released for use.
- Check the overall organization of the storage area, ensuring that products are properly positioned to allow adequate air circulation and that inventory is arranged to facilitate FIFO rotation.
- Verify that the temperature alarm system is functioning properly and that backup power supplies are adequate in case of electrical failure.
- Periodic quality assurance reviews
- Conduct monthly comprehensive inspections of the storage facility, including equipment calibration verification, monitoring system validation, and review of temperature excursion logs.
- Perform quarterly stability assessment reviews to evaluate any trends in product quality indicators and identify potential areas for improvement in storage practices.
- Maintain documentation of all storage-related activities, including maintenance performed on refrigeration equipment, calibration certificates, and staff training records, for a minimum period as required by local regulations.
Regulatory Guidelines and Manufacturer Recommendations
“GlutaOne 1200 mg (glutathione for injection) must be stored at 2–8 °C, protected from light and excessive moisture, in the original sealed container until the point of administration. Deviation from these conditions may affect the safety, purity, and potency of the product and could result in therapeutic failure or adverse patient outcomes. Healthcare providers bear responsibility for ensuring that storage conditions are maintained throughout the product’s journey from manufacturer to patient, including all handling, transportation, and storage activities. Any observed or suspected storage deviations should be reported immediately to the appropriate quality and regulatory authorities, and affected product should be quarantined pending investigation. The manufacturer recommends regular training for all personnel involved in product handling, with particular emphasis on temperature monitoring, packaging integrity assessment, and documentation requirements. Compliance with these storage guidelines is essential for ensuring that patients receive medication that meets the quality standards expected of pharmaceutical products intended for parenteral administration.”
Emergency Procedures and Contingency Planning
Facilities should develop and maintain contingency plans for situations where normal storage conditions cannot be assured. These plans should address power failures, equipment malfunctions, natural disasters, and other emergencies that could compromise product integrity. The contingency plan should include provisions for alternative storage arrangements, temperature monitoring during emergencies, product assessment procedures following excursions, and decision criteria for product disposition. Regular drills and scenario-based training can help ensure that staff are prepared to respond appropriately when emergencies occur.